one study published in the journal Cureus marked a significant association, arguing that ferritin levels are a notable biomarker for predicting acute hair loss
Despite accounting for 12.6% of global GLP-1 clinical trial activity in 2025, placing it third globally behind the US and China, prescribing rates for obesity indications remain comparatively low
The checker at the top of this page is free, and compares your weight loss with the clinical trial average for your medication at the same point in treatment
Clinical trials typically implemented a 500600 kcal daily deficit from baseline requirements, combined with increased physical activity
Over the past four years, the percentage of patients receiving a prescription for semaglutide has increased over 930%, a surge driven largely by the drug's use in helping patients lose weight, according to data from Epic Research shared with ABC News